We are a newly organized blank check company. We intend to focus our search for acquisition targets or initial business combination targets on the tech and biotech sectors.  We may consider an initial business combination with an entity with operations in China, including Hong Kong. (Incorporated in the Cayman Islands) 

We intend to focus our search on sectors that complement the expertise of our management team and to capitalize on the ability of our management team to identify and acquire a business. We particularly focus on the technology industries, particularly those in the biotechnology and pharmaceutical sectors. Our goal is to focus on middle market and emerging growth companies with global operations and overall enterprise values ranging from $100 million to $2 billion. We believe that acquiring a leading high-growth technology company or assets in the biotechnology or pharmaceutical industry will provide a platform to fund consolidation and fuel growth for our company. There are no restrictions on the geographical location of the targets we can pursue.

Our management team is led by Xu Zhenchun, CEO, chairman and director, and Zhu Fengping, CFO and director.

Xu Zhenchun has served as our chief executive officer and chairman since Aug. 15, 2023. Mr. Xu brings more than 30 years of experience in cross-border M&A, investment analysis, project management and new technology development research. He specialized in high-tech project investment analysis, strategic planning in mergers and acquisition. Since the beginning of 2023, Mr. Xu has served as the executive director of Everpower International Holdings Ltd. in the United States. He was responsible for technological innovation, investment analysis and project management. He has promoted the industrialization of major projects such as new energy vehicles and artificial intelligence as well as cross-border investment and mergers and acquisitions. He also promoted SPAC listings. Since 1998, Mr. Xu has served as a senior consultant to Oriental Rainbow Holdings (Hong Kong) Company Limited, an investment holding company.

Zhu Fengping has served as our chief financial officer since Aug. 15, 2023. Since September 2020, Ms. Zhu has served as the executive director and CFO of China Innovation Development Research Institute Co., Ltd. (CID). 

(Note: TechyBird Acquisition Corp. filed its S-1 on Dec. 6, 2023, and disclosed the terms for its SPAC IPO: 6.0 million units at $10.00 each to raise $60.0 million. Each unit consists of one share of common stock and one right entitling the holder to receive one-fifth (1/5) of a share of stock upon the consummation of the initial business combination. The blank check company filed confidential IPO documents with the SEC on Aug. 24, 2023.)